BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21796650)

  • 1. Prostate carcinoma cells LNCaP and glucan cooperate in induction of cytokine synthesis by dendritic cells: effect on natural killer cells and CD4+ lymphocytes activation.
    Donini M; Marongiu L; Fontana E; Dusi S
    Prostate; 2012 Apr; 72(5):566-76. PubMed ID: 21796650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.
    Gros F; Cabillic F; Toutirais O; Maux AL; Sebti Y; Amiot L
    Eur J Immunol; 2008 Mar; 38(3):742-9. PubMed ID: 18266268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.
    Kaliński P; Schuitemaker JH; Hilkens CM; Wierenga EA; Kapsenberg ML
    J Immunol; 1999 Mar; 162(6):3231-6. PubMed ID: 10092774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential.
    Vieira PL; Kaliński P; Wierenga EA; Kapsenberg ML; de Jong EC
    J Immunol; 1998 Nov; 161(10):5245-51. PubMed ID: 9820496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new immunosuppressive agent AEB071 on human immune cells.
    Matz M; Weber U; Mashreghi MF; Lorkowski C; Ladhoff J; Kramer S; Neumayer HH; Budde K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2159-67. PubMed ID: 20100729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD; Zhang WY; Yuan CL; Han LY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production.
    Jung MY; Son MH; Kim SH; Cho D; Kim TS
    J Immunol; 2011 Jun; 186(12):6848-59. PubMed ID: 21551364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
    Detournay O; Mazouz N; Goldman M; Toungouz M
    Hum Immunol; 2005 May; 66(5):460-8. PubMed ID: 15935883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine NK cells acquire cytotoxic activity and produce IFN-gamma after stimulation by Mycobacterium bovis BCG- or Babesia bovis-exposed splenic dendritic cells.
    Bastos RG; Johnson WC; Mwangi W; Brown WC; Goff WL
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):302-12. PubMed ID: 18514329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses.
    Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J
    J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation.
    D'Ambrosio A; Colucci M; Pugliese O; Quintieri F; Boirivant M
    J Leukoc Biol; 2008 Sep; 84(3):661-8. PubMed ID: 18562485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
    J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells.
    Gruenbacher G; Gander H; Nussbaumer O; Nussbaumer W; Rahm A; Thurnher M
    Cancer Res; 2010 Dec; 70(23):9611-20. PubMed ID: 20947520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Route of administration influences the antitumor effects of bone marrow-derived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model.
    Saika T; Satoh T; Kusaka N; Ebara S; Mouraviev VB; Timme TL; Thompson TC
    Cancer Gene Ther; 2004 May; 11(5):317-24. PubMed ID: 15044961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.